[HTML][HTML] Sphingolipids in obesity and correlated co-morbidities: the contribution of gender, age and environment

E Torretta, P Barbacini, NM Al-Daghri… - International Journal of …, 2019 - mdpi.com
This paper reviews our present knowledge on the contribution of ceramide (Cer),
sphingomyelin (SM), dihydroceramide (DhCer) and sphingosine-1-phosphate (S1P) in …

[HTML][HTML] Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a “Biochemical” Diagnosis of …

AE Rigamonti, M Dei Cas, D Caroli, A De Col… - International Journal of …, 2023 - mdpi.com
Metabolic syndrome is nosographically defined by using clinical diagnostic criteria such as
those of the International Diabetes Federation (IDF) ones, including visceral adiposity, blood …

[HTML][HTML] Circulating sphingolipids and glucose homeostasis: an update

S Ali-Berrada, J Guitton, S Tan-Chen… - International Journal of …, 2023 - mdpi.com
Sphingolipids are a family of lipid molecules produced through different pathways in
mammals. Sphingolipids are structural components of membranes, but in response to …

[HTML][HTML] Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults

H Hanamatsu, S Ohnishi, S Sakai, K Yuyama… - Nutrition & …, 2014 - nature.com
Objective: Recent studies indicate that sphingolipids, sphingomyelin (SM) and ceramide
(Cer) are associated with the development of metabolic syndrome. However, detailed …

[HTML][HTML] Circulating sphingolipids in insulin resistance, diabetes and associated complications

SM Hammad, MF Lopes-Virella - International Journal of Molecular …, 2023 - mdpi.com
Sphingolipids play an important role in the development of diabetes, both type 1 and type 2
diabetes, as well as in the development of both micro-and macro-vascular complications …

[HTML][HTML] Blood sphingolipidomics in healthy humans: impact of sample collection methodology

SM Hammad, JS Pierce, F Soodavar, KJ Smith… - Journal of lipid …, 2010 - ASBMB
We used a HPLC-MS/MS methodology for determination of a basic metabolomic profile (18:
1, 18: 0 sphingoid backbone, C 14-C 26 N-acyl part) of" normal" sphingolipid levels in …

Alterations of endogenous sphingolipid metabolism in cardiometabolic diseases: Towards novel therapeutic approaches

M Le Barz, MM Boulet, C Calzada, D Cheillan… - Biochimie, 2020 - Elsevier
The increasing prevalence of obesity and metabolic diseases is a worldwide public health
concern, and the advent of new analytical technologies has made it possible to highlight the …

[图书][B] Sphingolipids in obesity, type 2 diabetes, and metabolic disease

SB Russo, JS Ross, LA Cowart - 2013 - Springer
Metabolic disease, including obesity and type 2 diabetes, constitutes a major emerging
health crisis in Western nations. Although the symptoms and clinical pathology and …

[HTML][HTML] Role of circulating sphingolipids in lipid metabolism: Why dietary lipids matter

C Calzada, C Vors, A Penhoat, D Cheillan… - Frontiers in …, 2023 - frontiersin.org
Sphingolipids are structural components of cell membranes and lipoproteins but also act as
signaling molecules in many pathophysiological processes. Although sphingolipids …

Sphingolipids in high fat diet and obesity‐related diseases

S Choi, AJ Snider - Mediators of inflammation, 2015 - Wiley Online Library
Nutrient oversupply associated with a high fat diet (HFD) significantly alters cellular
metabolism, and specifically including sphingolipid metabolism. Sphingolipids are emerging …